Sputnik V Covid vaccine shows higher Omicron-specific antibodies than Pfizer: Study

The levels of Omicron-neutralising antibodies of people vaccinated with two doses of Russia’s Sputnik V vaccine did not decline as much as of those who had Pfizer shots, according to a small study. The joint Russian-Italian study — funded by the Russian Direct Investment Fund which markets Sputnik V — compared the blood serum samples of people taken three to six months after the second dose of the two vaccines. The yet-to-be peer-reviewed study, posted on the preprint repositor